Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 8, keine Gesamtzahl für „enzymes“
Suchtreffer
Begriffe & Kennungen
Fettsäure-Desaturasen
Eintrag öffnenFingolimod Accord · 4.5 · Fingolimod is metabolised mainly by CYP4F2. Other enzymes like CYP3A4 may also contribute to its metabolism, n
Eintrag öffnenFingolimod Accord · 4.5 · Fingolimod is unlikely to interact with substances mainly cleared by the CYP450 enzymes or by substrates of th
Eintrag öffnenFingolimod Accord · 4.8 · Liver function Increased hepatic enzymes have been reported in adult and paediatric multiple sclerosis patient
Eintrag öffnenFirdapse (previously Zenas) · 4.5 · Substances which are potent inducers of enzymes that metabolise medicinal products (see section 5.2) The resul
Eintrag öffnenFirdapse (previously Zenas) · 4.5 · Substances which are potent inhibitors of enzymes that metabolise medicinal products (see section 5.2) Potent
Eintrag öffnenFycompa · 4.5 · 9 (2-fold), which are known inducers of enzymes of metabolism (see section 5.2). This effect should be taken i
Eintrag öffnenFycompa · 4.5 · Fycompa is not considered a strong inducer or inhibitor of cytochrome P450 or UGT enzymes (see section 5.2).
Eintrag öffnenFycompa · 4.5 · Fycompa is not considered a strong inducer or inhibitor of cytochrome P450 or UGT enzymes (see section 5.2).
Eintrag öffnenGazyvaro · 4.8 · Transient elevation in liver enzymes (aspartate aminotransferase [AST], alanine aminotransferase [ALT], alkali
Eintrag öffnenGilenya · 4.5 · Fingolimod is metabolised mainly by CYP4F2. Other enzymes like CYP3A4 may also contribute to its metabolism, n
Eintrag öffnenGilenya · 4.5 · Fingolimod is unlikely to interact with substances mainly cleared by the CYP450 enzymes or by substrates of th
Eintrag öffnenGilenya · 4.8 · 17 Liver function Increased hepatic enzymes have been reported in adult and paediatric multiple sclerosis pati
Eintrag öffnenGlyxambi · 4.5 · 7 induction by rifampicin or phenytoin) has not been studied. Co-treatment with known inducers of UGT enzymes
Eintrag öffnenGlyxambi · 4.5 · Co-administration of empagliflozin with probenecid, an inhibitor of UGT enzymes and OAT3, resulted in a 26% in
Eintrag öffnenHELLP-Syndrom
Eintrag öffnenHalaven · 4.5 · Eribulin does not inhibit the CYP enzymes CYP1A2, 2B6, 2C8, 2C9, 2C19, 2D6 or 2E1 at relevant clinical concent
Eintrag öffnenHalaven · 4.8 · Hepatotoxicity In some patients with normal/abnormal liver enzymes prior treatment with eribulin, increased le
Eintrag öffnenHefiya · 4.8 · 20 System Organ Class Frequency Adverse Reaction Hepato-biliary Very common Elevated liver enzymes disorders*
Eintrag öffnenHefiya · 4.8 · Hepato-biliary Very common Elevated liver enzymes disorders* Uncommon Cholecystitis and cholelithiasis, hepati
Eintrag öffnen